New Medications for Neuropsychiatric Disorders

This article seeks to summarize the mechanisms of action, clinical trials, and FDA approval status of several psychiatric medications that are either newly available or in the FDA approval process. This article highlights medications that demonstrate novel mechanisms of action, examines nonpsychiatric medications that are being used to augment existing psychiatric treatments, and elucidates treatments for illnesses that have not previously received FDA indications.

Source: The Psychiatric Clinics of North America - April 7, 2020 Category: Psychiatry Authors: Harika M. Reddy, Joshua S. Poole, Gerald A. Maguire, Stephen M. Stahl Source Type: research